Cargando…
LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a serious metabolic disorder characterized by excess fat accumulation in the liver. Over the past decade, NAFLD prevalence and incidence have risen globally. There are currently no effective licensed drugs for its treatment. Thus, further study is required...
Autores principales: | Lee, Jibeom, Kim, Hyeonhui, Kang, Yun-Won, Kim, Yumin, Park, Moon-young, Song, Ji-Hong, Jo, Yunju, Dao, Tam, Ryu, Dongryeol, Lee, Junguee, Oh, Chang-Myung, Park, Sangkyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394021/ https://www.ncbi.nlm.nih.gov/pubmed/37394588 http://dx.doi.org/10.1038/s12276-023-01033-w |
Ejemplares similares
-
Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
por: Jang, Hyun-Jun, et al.
Publicado: (2023) -
Machine learning-featured Secretogranin V is a circulating diagnostic biomarker for pancreatic adenocarcinomas associated with adipopenia
por: Jo, Yunju, et al.
Publicado: (2022) -
L-threonine promotes healthspan by expediting ferritin-dependent ferroptosis inhibition in C. elegans
por: Kim, Juewon, et al.
Publicado: (2022) -
Exploring the Genetic Associations Between the Use of Statins and Alzheimer's Disease
por: Lee, Jibeom, et al.
Publicado: (2022) -
A Systems Biology Approach to Investigating the Interaction between Serotonin Synthesis by Tryptophan Hydroxylase and the Metabolic Homeostasis
por: Park, Suhyeon, et al.
Publicado: (2021)